Home LiteratureArticle Details
PMID: 2668563 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin.

Journal of virology ·Vol. 63 ·No. 9 ·1989-09-00 ·Pages 4051-4

Liebowitz D, Kieff E

Abstract

The latent membrane protein (LMP) of Epstein-Barr virus (EBV) forms patches associated with the vimentin intermediate filament system in EBV-transformed lymphoblastoid cell lines, EBV-infected Burkitt's lymphoma cells, and LMP-transfected, EBV-negative Burkitt's lymphoma cells. By gene transfer, LMP induces the expression of vimentin and B-cell activation antigens in EBV-negative Burkitt's lymphoma cells. We have now expressed LMP in an EBV-positive Burkitt's lymphoma cell line, Daudi, which does not express any LMP or vimentin. In these Daudi transfectants, LMP still formed plasma membrane patches in the absence of vimentin. LMP did not resist nonionic detergent extraction in Daudi cells as it does in vimentin-expressing cells. LMP still retained functional activity as judged by induction of B-cell activation antigens. These data indicate that LMP can form plasma membrane patches and induce B-lymphocyte activation independent of vimentin association.

MeSH Terms
Antigens, Differentiation/biosynthesis Antigens, Surface/biosynthesis Antigens, Viral/physiology B-Lymphocytes/immunology Cell Adhesion Molecules Cell Membrane Humans Lymphocyte Activation Lymphocyte Function-Associated Antigen-1 Vimentin/physiology Viral Matrix Proteins
Chemicals
Antigens, Differentiation Antigens, Surface Antigens, Viral Cell Adhesion Molecules EBV-associated membrane antigen, Epstein-Barr virus Lymphocyte Function-Associated Antigen-1 Vimentin Viral Matrix Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Liebowitz D
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.
Kieff E
References (16)
16 references, click to expand
  1. Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus.
    Nature. 1981 Dec 3;294(5840):458-60 PMID: 6273741
  2. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity.
    J Virol. 1988 Nov;62(11):4173-84 PMID: 2845129
  3. Epstein-Barr virus infection and immunoregulation in man.
    Adv Immunol. 1985;37:99-149 PMID: 2988307
  4. Early events in Epstein-Barr virus infection provide a model for B cell activation.
    J Exp Med. 1985 Jul 1;162(1):45-59 PMID: 2989413
  5. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.
    Cell. 1985 Dec;43(3 Pt 2):831-40 PMID: 3000618
  6. Epstein-Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma.
    Int J Cancer. 1986 Mar 15;37(3):367-73 PMID: 3005176
  7. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus.
    J Virol. 1986 Apr;58(1):233-7 PMID: 3005654
  8. Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth.
    Immunology. 1986 Aug;58(4):591-5 PMID: 2426189
  9. EBV-activation of human B-lymphocytes.
    Curr Top Microbiol Immunol. 1986;132:266-71 PMID: 3024919
  10. Vimentin gene: expression in human lymphocytes and in Burkitt's lymphoma cells.
    EMBO J. 1986 Nov;5(11):2809-14 PMID: 3792301
  11. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6 PMID: 3033649
  12. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes.
    Mol Cell Biol. 1987 Jul;7(7):2299-308 PMID: 3039344
  13. Coordinated action of IgE and a B-cell-stimulatory factor on the CD23 receptor molecule up-regulates B-lymphocyte growth.
    Proc Natl Acad Sci U S A. 1987 Sep;84(17):6239-43 PMID: 2957693
  14. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
    Proc Natl Acad Sci U S A. 1987 Nov;84(22):8060-4 PMID: 2825176
  15. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts.
    J Virol. 1988 Jul;62(7):2337-46 PMID: 2836616
  16. The EB virus genome in Daudi Burkitt's lymphoma cells has a deletion similar to that observed in a non-transforming strain (P3HR-1) of the virus.
    EMBO J. 1984 Apr;3(4):813-21 PMID: 6327290
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1989-09-00
Pages
4051-4
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC251005
Subset
IM
Grants
NCI NIH HHS · CA47006 · United States
NIGMS NIH HHS · GM07281 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]